WDR63
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
185529628rs6576745TCrs65767451.85E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
185531711rs6695223CTrs66952233.32E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
185531711rs6695223CTrs66952235.00E-09FACTOR VIIITRANSCRIPTION FACTORS|HOMEODOMAIN PROTEINS|IRX3 PROTEIN, HUMANVenous thromboembolism (gene x gene interaction)HPOID:0002204|HPOID:0002625DOID:866|DOID:9477CintronGWASdb_drug
185560264rs709764GArs7097643.79E-05TOPIRAMATE|FRUCTOSEANTICONVULSANTSCognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_drug
185529628rs6576745TCrs65767451.85E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
185531711rs6695223CTrs66952233.32E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
185531711rs6695223CTrs66952235.00E-09Venous thromboembolism (gene x gene interaction)HPOID:0002204|HPOID:0002625DOID:866|DOID:9477CintronGWASdb_trait
185537706rs17099213TCrs170992131.70E-05Urinary metabolitesHPOID:0000079DOID:557TintronGWASdb_trait
185539127rs17120570GArs171205702.88E-04Smoking initiationHPOID:0000707DOID:0050742GintronGWASdb_trait
185560264rs709764GArs7097643.79E-05Cognitive impairment induced by topiramateHPOID:0100543DOID:1561CintronGWASdb_trait
185582549rs2050842GArs20508424.60E-05Diabetic retinopathyHPOID:0000819|HPOID:0000488DOID:8947AintronGWASdb_trait
185583162rs6576749CGrs65767494.60E-05Diabetic retinopathyHPOID:0000819|HPOID:0000488DOID:8947GintronGWASdb_trait
Disease associated variation - GWAS Central
Study NameSource Marker AccessionChromosomeMarker StartMarker StopAllelesGene SectionP-value-log(p-value)
GWAS of prostate cancerrs81747618559674985596749intronic0.982520.00765860044237463
GWAS of prostate cancerrs1207957118554116485541164intronic0.9270620.0328912201624376
GWAS of prostate cancerrs81748218557805785578057intronic0.6173930.209438298855555
GWAS of prostate cancerrs447576918558414985584149intronic0.3033980.517987286409627
GWAS of prostate cancerrs177069118555679185556791intronic0.3015020.520709802641299
GWAS of prostate cancerrs669522318553171185531711intronic0.2777660.55632091524371
GWAS of prostate cancerrs70976418556026485560264intronic0.2178760.6617906065670439
GWAS of prostate cancerrs81747318559003185590031intronic0.1351980.869029732916486
GWAS of prostate cancerrs103774218553980485539804intronic0.1187110.92550903658071
GWAS of prostate cancerrs102646918556897285568972intronic0.0471941.3261132118007901
GWAS of prostate cancerrs154242718555440285554402intronic0.0152951.8154505186793002
GWAS of prostate cancerrs70976718556195485561954intronic0.0144791.8392614318874199
GWAS of prostate cancerrs70978318559446685594466exonic0.9985790.000617571347219405